Article Figures & Data
Tables
VARIABLES N (%)* Sex • Male 207 (46.0) • Female 243 (54.0) Age, y • < 30 2 (0.4) • 30–39 113 (24.8) • 40–49 160 (35.1) • 50–59 134 (29.4) • ≥ 60 47 (10.3) Practising family medicine, y • 1–5 72 (15.6) • 6–10 73 (15.8) • 11–15 71 (15.3) • 16–20 75 (16.2) • ≥21 172 (37.1) Population of community served • < 10 000 73 (15.9) • 10 000–99 999 95 (20.7) • 100 000–499 999 123 (26.8) • 500 000–1 000 000 63 (13.7) • > 1 000 000 105 (22.9) Practice format • Group 354 (76.3) • Single or other 110 (23.7) Teaching or university affiliation • Yes 183 (42.5) • No 248 (57.5) Recall reading ColonCancerCheck pamphlet • Yes 398 (86.9) • No 30 (6.6) • Unsure 29 (6.3) • Did not receive the information package 1 (0.2) Perceived knowledge of CRC screening (1 = novice; 3 = average; 5 = expert) • 1 3 (0.6) • 2 7 (1.5) • 3 249 (53.9) • 4 177 (38.3) • 5 26 (5.6) -
CRC—colorectal cancer.
-
↵* A total of 465 surveys were received. Any deviation from this number in the total responses represents missing data (eg, abstain, unclear responses).
-
RESPONSES N (%)* Preference for personal CRC screening • FOBT every 2 y 181 (39.6) • Colonoscopy every 10 y 232 (50.8) • Flexible sigmoidoscopy every 5 y 2 (0.4) • Flexible sigmoidoscopy with FOBT every 5 y 23 (5.0) • Double-contrast barium enema every 5 y 1 (0.2) • None of the above 18 (3.9) Perceived patient preference for CRC screening • FOBT every 2 y 288 (64.1) • Colonoscopy every 10 y 130 (29.0) • Flexible sigmoidoscopy every 5 y 1 (0.2) • Flexible sigmoidoscopy with FOBT every 5 y 17 (3.8) • Double-contrast barium enema every 5 y 2 (0.4) • None of the above 11 (2.4) Average wait time for colonoscopy in community, mo • < 2 82 (17.9) • 2–6 231 (50.5) • 6–12 106 (23.2) • 12–18 29 (6.3) • > 18 9 (2.0) Perceived sensitivity of a single standard FOBT kit, % • 0–19 41 (8.9) • 20–39 102 (22.2) • 40–59 153 (33.3) • 60–79 127 (27.7) • 80–100 36 (7.8) Screening modality that will have the greatest effect on the reduction of CRC mortality in Ontario • FOBT every 2 y 93 (20.9) • Colonoscopy every 10 y 242 (54.4) • Flexible sigmoidoscopy every 5 y 5 (1.1) • Flexible sigmoidoscopy with FOBT every 5 y 44 (9.9) • Double-contrast barium enema every 5 y 2 (0.4) • None of the above 6 (1.3) • Do not know 53 (11.9) Most cost-effective CRC screening modality • FOBT every 2 y 302 (66.1) • Colonoscopy every 10 y 62 (13.6) • Flexible sigmoidoscopy every 5 y 1 (0.2) • Flexible sigmoidoscopy with FOBT every 5 y 23 (5.0) • Double-contrast barium enema every 5 y 3 (0.7) • None of the above 3 (0.7) • Do not know 63 (13.8) -
CRC—colorectal cancer, FOBT—fecal occult blood testing.
-
↵* A total of 465 surveys were received. Any deviation from this number in the total responses represents missing data (eg, abstain, unclear responses); percentages do not add to 100% owing to rounding.
-
- Table 3
Respondents’ choice of personal CRC screening modality, by responses to CRC screening–related questions
QUESTIONS SCREENING PREFERENCE OF RESPONDENTS NO. OF RESPONSES* 
PVALUE FOBT N (%) COLONOSCOPY N (%) OTHER N (%) What would your patients most want for their own screening? 444 150.5 < .001 • FOBT every 2 y 157 (55.3) 106 (37.3) 21 (7.4) • Colonoscopy every 10 y 17 (13.2) 108 (83.7) 4 (3.1) • Other 5 (16.1) 10 (32.3) 16 (51.6) What is the wait time for colonoscopy in your community? 450 4.312 .37 • 0–6 mo 129 (42.0) 146 (47.6) 32 (10.4) • 6–12 mo 37 (35.2) 61 (58.1) 7 (6.7) • > 12 mo 13 (34.2) 21 (55.3) 4 (10.5) What is the sensitivity of a single FOBT kit? 452 14.75 .005 • < 40% 48 (34.0) 78 (55.3) 15 (10.6) • 40%–59% 48 (31.8) 89 (58.9) 14 (9.3) • ≥ 60% 81 (50.6) 64 (40.0) 15 (9.4) Which screening modality will have the greatest effect on the reduction of CRC-related mortality in Ontario? 388 113.3 < .001 • FOBT every 2 y 60 (65.9) 26 (28.6) 5 (5.5) • Colonoscopy every 10 y 59 (24.6) 169 (70.4) 12 (5.0) • Other 26 (45.6) 11 (19.3) 20 (35.1) What is the most cost-effective method of CRC screening in Ontario? 389 87.12 < .001 • FOBT every 2 y 145 (48.5) 134 (44.8) 20 (6.7) • Colonoscopy every 10 y 5 (8.3) 53 (88.3) 2 (3.3) • Other 5 (16.7) 12 (40.0) 13 (43.3) -
CRC—colorectal cancer, FOBT—fecal occult blood testing.
-
↵* A total of 465 surveys were received. Any deviation from this number in the total responses represents missing data (eg, abstain, unclear responses); percentages do not add to 100% owing to rounding.
-
